GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » icad Inc (NAS:ICAD) » Definitions » Shiller PE Ratio

icad (ICAD) Shiller PE Ratio : (As of Apr. 30, 2024)


View and export this data going back to 1992. Start your Free Trial

What is icad Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


icad Shiller PE Ratio Historical Data

The historical data trend for icad's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

icad Shiller PE Ratio Chart

icad Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

icad Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of icad's Shiller PE Ratio

For the Medical Devices subindustry, icad's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


icad's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, icad's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where icad's Shiller PE Ratio falls into.



icad Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

icad's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, icad's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.05/129.4194*129.4194
=0.050

Current CPI (Dec. 2023) = 129.4194.

icad Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.020 99.695 -0.026
201406 -0.070 100.560 -0.090
201409 0.020 100.428 0.026
201412 -0.010 99.070 -0.013
201503 -0.120 99.621 -0.156
201506 -1.770 100.684 -2.275
201509 -0.030 100.392 -0.039
201512 -0.150 99.792 -0.195
201603 -0.160 100.470 -0.206
201606 -0.100 101.688 -0.127
201609 -0.170 101.861 -0.216
201612 -0.200 101.863 -0.254
201703 -0.030 102.862 -0.038
201706 -0.160 103.349 -0.200
201709 -0.420 104.136 -0.522
201712 -0.260 104.011 -0.324
201803 -0.200 105.290 -0.246
201806 -0.060 106.317 -0.073
201809 -0.080 106.507 -0.097
201812 -0.200 105.998 -0.244
201903 -0.220 107.251 -0.265
201906 -0.200 108.070 -0.240
201909 -0.150 108.329 -0.179
201912 -0.170 108.420 -0.203
202003 -0.590 108.902 -0.701
202006 -0.110 108.767 -0.131
202009 -0.080 109.815 -0.094
202012 -0.070 109.897 -0.082
202103 -0.070 111.754 -0.081
202106 -0.130 114.631 -0.147
202109 -0.090 115.734 -0.101
202112 -0.170 117.630 -0.187
202203 -0.140 121.301 -0.149
202206 -0.120 125.017 -0.124
202209 -0.150 125.227 -0.155
202212 -0.120 125.222 -0.124
202303 -0.150 127.348 -0.152
202306 -0.070 128.729 -0.070
202309 -0.050 129.860 -0.050
202312 0.050 129.419 0.050

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


icad  (NAS:ICAD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


icad Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of icad's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


icad (ICAD) Business Description

Traded in Other Exchanges
N/A
Address
98 Spit Brook Road, Suite 100, Nashua, NH, USA, 03062
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company reports in two segments: Detection and Therapy. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
Executives
Eric Lonnqvist officer: See Remarks 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 02062
Daniel Joseph Shea officer: See Remarks 2 MINUTEMAN ROAD, MEDFIELD MA 02052
Jonathan Go officer: Sr. VP of R&D C/O ICAD, INC., 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
Stephen P Sarno officer: See Remarks C/O SAPIENT CORPORATION, 25 FIRST STREET, CAMBRIDGE MA 02141
Andy Sassine director 82 DEVONSHIRE STREET, BOSTON MA 02109
Dana R Brown director 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
Timothy Norris Irish director 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
Nathaniel Dalton director C/O AFFILIATED MANAGERS GROUP INC, 777 S. FLAGLER DR., SUITE 1201 E. TOWER, WEST PALM BEACH FL 33401
Susan Alyson Wood director 845 MORENO AVENUE, PALO ALTO CA 94303
Michael S Klein director C/O ICAD INC, 98 SPIT BROOK ROAD SUITE 100, NASHUA NH 03062
Charles Ross Carter officer: See Remarks C/O GI DYNAMICS, INC., 745 ATLANTIC AVENUE, BOSTON MA 02111
Stacey M Stevens officer: Executive VP of Marketing C/O ICAD, INC., 98 SPIT BROOK ROAD, SUITE 100, NASHUA NH 03062
R. Scott Areglado officer: Interim Chief FinancialOfficer 98 SPIT BROOK ROAD, SUITE 100, C/O ICAD, INC., NASHUA NH 03062
Rakesh Patel director 15400 NATIONAL AVENUE, LOS GATOS CA 95032
Dr Lawrence Howard director C/O PRESSTEK INC, 2 GREENWICH OFFICE PARK, GREENWICH CT 06831